Masahiro Yokoyama Selected Research

Masahiro Yokoyama Research Topics

Disease

16	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 08/2007
11	Neoplasms (Cancer) 05/2019 - 05/2005
9	Lymphoma (Lymphomas) 01/2021 - 01/2006
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 01/2006
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2021 - 05/2009
5	B-Cell Lymphoma (Lymphoma, B Cell) 04/2021 - 01/2008
5	Breast Neoplasms (Breast Cancer) 05/2020 - 01/2006
4	Neutropenia 04/2021 - 08/2010
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2019 - 04/2009
3	Infections 11/2017 - 12/2010
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 04/2009
2	Febrile Neutropenia 04/2021 - 11/2017
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021 - 05/2012
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 05/2020 - 07/2014
2	Fever (Fevers) 02/2020 - 11/2017
2	Multiple Myeloma 01/2020 - 05/2014
2	Anemia 05/2014 - 01/2013
2	Thrombocytopenia (Thrombopenia) 11/2013 - 08/2010
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 09/2013 - 11/2007
2	Stomatitis 09/2012 - 05/2011
2	Head and Neck Neoplasms (Head and Neck Cancer) 09/2012 - 05/2011
2	Neuroendocrine Carcinoma 08/2012 - 05/2005
2	Anorexia 04/2012 - 08/2010
2	Nausea 04/2012 - 08/2010
1	Hematologic Neoplasms (Hematological Malignancy) 12/2015
1	Hodgkin Disease (Hodgkin's Disease) 07/2014
1	Tumor Lysis Syndrome 05/2014
1	Thrombotic Thrombocytopenic Purpura 11/2013
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2013
1	Esophageal Neoplasms (Esophageal Cancer) 09/2012
1	Colorectal Neoplasms (Colorectal Cancer) 09/2012
1	Abdominal Pain (Pain, Abdominal) 04/2012
1	Fatigue 04/2012
1	Diarrhea 04/2012
1	Leukopenia 08/2010
1	Lymphopenia (Lymphocytopenia) 08/2010

Drug/Important Bio-Agent (IBA)

21	Rituximab (Mabthera)FDA Link 01/2021 - 01/2006
6	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 05/2008
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 05/2008
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 05/2008
4	Cisplatin (Platino)FDA LinkGeneric 08/2012 - 05/2005
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2021 - 11/2017
3	Prednisone (Sone)FDA LinkGeneric 01/2021 - 05/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2020 - 08/2010
3	Docetaxel (Taxotere)FDA Link 05/2011 - 05/2005
3	Complement System Proteins (Complement)IBA 05/2009 - 01/2006
2	obinutuzumabIBA 11/2021 - 01/2013
2	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 11/2013
2	Bortezomib (Velcade)FDA Link 01/2020 - 05/2014
2	Biological ProductsIBA 04/2018 - 01/2013
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2015 - 10/2013
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2014 - 01/2013
2	Oxidoreductases (Dehydrogenase)IBA 05/2014 - 01/2013
2	LactaseIBA 05/2014 - 01/2013
2	Thymidine KinaseIBA 11/2013 - 05/2012
2	AntibodiesIBA 01/2013 - 01/2006
2	Proteins (Proteins, Gene)FDA Link 01/2006 - 06/2004
1	Bendamustine Hydrochloride FDA Link 01/2022
1	polatuzumab vedotinIBA 01/2021
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 02/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	Lenalidomide (CC 5013)FDA Link 01/2020
1	Biomarkers (Surrogate Marker)IBA 05/2019
1	tirabrutinibIBA 05/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 05/2019
1	Immunoglobulins (Immunoglobulin)IBA 02/2018
1	Immunoglobulin G (IgG)IBA 02/2018
1	R-CHOP protocolIBA 11/2017
1	Brentuximab VedotinIBA 07/2014
1	CreatinineIBA 05/2014
1	AlbuminsIBA 05/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2013
1	SaltsIBA 11/2013
1	PlatinumIBA 11/2013
1	Heparin (Liquaemin)FDA LinkGeneric 11/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2013
1	ofatumumab FDA Link 05/2013
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2013
1	C-Reactive ProteinIBA 01/2013
1	Hemoglobins (Hemoglobin)IBA 01/2013
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2012
1	Epidermal Growth Factor (EGF)IBA 04/2012
1	neratinibIBA 04/2012
1	AlginatesIBA 05/2011
1	SolutionsIBA 05/2011
1	SuspensionsIBA 05/2011
1	Fluorouracil (Carac)FDA LinkGeneric 05/2011
1	polaprezinc (Z 103)IBA 05/2011
1	Pharmaceutical PreparationsIBA 08/2010
1	Inotuzumab OzogamicinIBA 08/2010
1	CalicheamicinsIBA 08/2010

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 01/2017 - 05/2005
12	Therapeutics 11/2021 - 01/2006
2	Drug Tapering 04/2021 - 09/2012
2	Radiotherapy 09/2012 - 05/2010
2	Combination Drug Therapy (Combination Chemotherapy) 08/2012 - 01/2008
1	VAP-cyclo protocol 01/2021
1	Breast Implants (Breast Implant) 05/2020
1	Adjuvant Chemotherapy 10/2013
1	Salvage Therapy 01/2013